Skip to main content

Table 2 The clinical characteristics of health management cohort from Tangshan

From: Large-scale in silico identification of drugs exerting sex-specific effects in the heart

  Men Women P values
N 86 67  
Age 55.23 ± 10.56 59.55 ± 7.65 0.0039
SBP (mmHg) 149.2 ± 16.45 153.3 ± 20.84 0.1809
DBP (mmHg) 96.63 ± 11.44 89.27 ± 13.43 0.0004
HR (bmp) 72.66 ± 11.61 72.48 ± 14.07 0.9362
BMI (kg/m2) 26.78 ± 2.99 26.42 ± 3.52 0.4875
Glu (mM) 6.21 ± 2.04 6.11 ± 2.02 0.7596
TG (mM) 1.93 ± 1.29 2.29 ± 1.72 0.1581
TC (mM) 4.74 ± 1.01 5.17 ± 0.87 0.0067
HDL-c (mM) 1.08 ± 0.18 1.21 ± 0.28 0.0015
LDL-c (mM) 2.74 ± 0.65 2.93 ± 0.60 0.0599
Other medication ACEI (1) ACEI (4)  
ARB (3) ARB (1)  
CCB (11) CCB (5)  
Diuretics (3) Diuretics (1)  
Co-morbidities Diabetes (29) Diabetes (15)  
Stroke (6) CHD (3)  
  1. SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, BMI body mass index, Glu fasting serum glucose, TG serum triglyceride, TC serum total cholesterol, HDL high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium channel blockers, CHD coronary heart disease